Previous studies examining an association with other disease, autoimmune thyroid disease (and Graves' disease in particular) contributes disproportionately to the excess autoimmune diseases have suggested the existence of a generalized autoimmune diathesis in patients with risk. There was no increase in autoimmune disease within patients with multiple sclerosis themselves when compared multiple sclerosis. We investigated the prevalence of autoimmune disease in first-degree relatives of probands with the index controls or population data. We conclude that autoimmune disease is more common in first-degree with multiple sclerosis using a case-control method. The results show an excess of autoimmune disease within these relatives of patients with multiple sclerosis and hypothesize that common genetic susceptibility factors families, but no significant association was seen with nonautoimmune diseases. The higher risk in multiplex than for autoimmunity co-exist with additional disease specific genetic or environmental factors, which determine clinical simplex families suggests an effect of genetic loading. While the increase in risk applies to each autoimmune phenotype in the individual.
Introduction
Autoimmune disease is characterized by humoral or cell with other conditions, is well recognized in multiple sclerosis (Spadaro et al., 1999) . The significance of this finding is less mediated immune response to self-antigen. This may be organ specific or systemic and, given the various overlap clear since these autoantibodies are not usually associated with clinical evidence of disease (Baker et al., 1972) . The syndromes and occurrence of more than one autoimmune disease in the same patient (Sheehan and Stanton-King, hallmark of multiple sclerosis as an autoimmune disease is the perivascular accumulation of autoreactive T cells 1993), the different phenotypes are thought to represent a spectrum of immune dysregulation (Gordon and Isenberg, (Stinissen et al., 1998) . There are occasional case reports linking multiple sclerosis 1990). Multiple sclerosis shares many clinical and pathological characteristics of prototypical autoimmune and autoimmune disease within families (McCombe et al., 1990) , and one case-control study looking at the risk of diseases (Hafler and Weiner, 1989) .
The majority of autoimmune diseases, including multiple chronic inflammatory disease within the immediate family members of patients with multiple sclerosis (Midgard et al., sclerosis , are more common in women and show an increasing prevalence throughout adult life with peak incidence between 1996). This and other studies (Warren and Warren, 1982) suggest an association with diabetes, but others have failed the ages of 20 and 40 years (Beeson, 1994) . A tendency for remission during pregnancy, with a transient deterioration or to show any familial link between these disorders (Alter and Sawyer, 1970) . However, none of these studies has sufficient increased incidence of onset in the puerperium, has been reported for several autoimmune diseases (Mitchell and sample size to be definitive and each fails to make the distinction between type 1 and type 2 diabetes. Bebbington, 1992; Tada et al., 1994; Nelson and Ostensen, 1997) , including multiple sclerosis (Confavreux et al., 1998) , As part of ongoing genetic studies in multiple sclerosis, we have accumulated a large cohort of simplex and multiplex and each shows a variable response to immunosuppressive therapy. The presence of autoantibodies, usually associated families from throughout the UK. We have conducted a retrospective case-control postal questionnaire survey in were investigated because of previous reports linking these diseases with individuals having multiple sclerosis (Rang order to assess whether autoimmune disease is more common in first-degree relatives of probands with multiple sclerosis.
et al., 1982) and their families (Minuk and Lewkonia, 1986; Sadovnick et al., 1989) . Non-autoimmune diseases were considered in order to control for reporting bias. 'Heart attack' was included in the
Methods
Power calculations indicated that 250 cases and 250 controls list of conditions, and age of onset of a disease was requested allowing a differentiation to be made between type 1 and would be required to demonstrate a twofold increase in the risk of autoimmune disease, with α (the probability of a false type 2 diabetes, so that type 2 would provide a further nonautoimmune control. The cut-off was made at 30 years, positive, i.e. type 1 error, result) ϭ 0.05 and β (the probability of a false negative, i.e. type 2 error, result) ϭ 0.2, assuming recognizing that this is arbitrary and that some cases of later onset diabetes are also autoimmune in nature. Atopic asthma a background prevalence of 2.5% (Table 1) and an average of three relatives per family. A larger sample size was was included as an 'immunological' control condition; there are reports linking atopy with multiple sclerosis (Frovig predicted for unequal sample sizes, but this requirement is counteracted by the use of simplex and multiplex families in et al., 1967) , although this is unconfirmed and others have found a reduced prevalence in patients with multiple sclerosis order to measure dosage effect. Multiplex families were defined as a proband with one or more first-degree relatives (Oro et al., 1996) . Two identical questionnaires, one to be completed by the having multiple sclerosis. Ethical approval was obtained from the local Cambridge (CREC) and Oxford and Cambridge proband and the other by a control, were distributed. A reminder letter was sent to non-responders after 2 months. Regional Ethics Committee (MREC).
The patients were 773 cases referred by members of the Controls were selected by the probands from a choice of spouse, partner, carer or friend. The questionnaire requested Association of British Neurologists from throughout the UK, or those volunteering for participation in research through information about the list of specific autoimmune and nonautoimmune conditions in parents and siblings. Information the Multiple Sclerosis Society of Great Britain and Northern Ireland, and Brunel University. Inclusion criteria about offspring was not requested because of ethical issues relating to informed consent in those aged under 18 years. were a confirmed diagnosis of multiple sclerosis made by a consultant neurologist, Caucasian origin and living parents Since the rate of autoimmune disease in childhood is low, this group would be relatively uninformative. Relevant born in the UK. Probands were excluded if they failed to meet the Poser criteria for a diagnosis of clinically definite information regarding each condition was provided and it was requested that all living relatives be asked directly (Poser et al., 1983) , laboratory-supported definite or laboratory-supported probable multiple sclerosis (categories about these conditions and for information from memory on deceased relatives. Where there was any doubt about a A-C). All multiple sclerosis probands were visited to establish the diagnosis and record clinical details. Confirmation of particular relative, participants were instructed to reply in the affirmative, so as to increase the likelihood of including all the diagnosis was made using medical records, and where applicable, results of MRI, visual evoked potentials and CSF positive diagnoses. Informed consent for participation in the study was obtained from all index cases and controls. examination were obtained.
The autoimmune diseases selected for study are the most On receipt of completed questionnaires all living relatives said to have one of the listed conditions were contacted to prevalent of those with recognized associated autoantibodies (Patrick, 1993) . Their overall population prevalence in the request confirmation from their general practitioner. A repeat mail-shot was sent to non-responders after a further 2 months. UK is 2.5% (Table 1) . Psoriasis was also considered as a putative T-cell mediated autoimmune disease (Barker, 1998) Consent to release of medical information was obtained and further specific details relating to asthma (atopy, age of onset but analysed separately. Crohn's disease and ulcerative colitis and smoking history) and thyroid disease (previous surgery, been originally visited for other aspects of genetic research more than 4 years prior to the postal survey. This suggests thyroxine replacement therapy and specific diagnoses) were requested. It was therefore possible to distinguish atopic that many of the non-responders may never have received the questionnaires due to inadequate postal details or through asthma from non-atopic asthma and primary hypothyroidism and hyperthyroidism from other secondary causes of thyroid having moved since originally being recruited. Disease severity did not influence the likelihood of response and this disease. Atopic asthma was defined as asthma beginning before the age of 20 years, asthma with atopic features (hay may reflect the option that the questionnaire be completed, if necessary, by another relative or carer on behalf of the fever or eczema) commencing before the age of 30 years, or asthma with atopic features prior to the age of 50 years in proband. In total, the survey included 3439 relatives of 946 index cases and controls. Thirty-two half-siblings were persons who had never been smokers. For the purposes of analysis, primary hypothyroidism and hyperthyroidism were excluded from the analysis. One thousand individuals were contacted regarding positive diagnoses, of whom 879 replied. assumed to have an autoimmune basis and were included with Hashimoto's thyroiditis and Graves' disease, respectively. The majority of cases with primary hyperthyroidism are due to Graves' disease, but the remainder usually also have an
Diagnostic confirmation
The number of general practitioners contacted was 799, of autoimmune basis (predominantly Hashimoto's thyroiditis).
General practitioners were contacted to confirm or refute whom 722 responded. It was therefore possible to confirm the diagnosis of autoimmune disease through general each diagnosis. Three options were given: 'yes', the diagnosis is correct; 'no', this person has never had this disease; or practitioners in 78% of living affected relatives. The figure for all diagnoses was 75%. The positive predictive value of 'uncertain', it is not possible to confirm or deny this diagnosis based on personal knowledge and the available medical diagnoses in living relatives initially reported by the index case or control for each condition is listed in Table 2 . With records. Only affirmative responses have been included in the analysis. Demographic details and all diagnostic data the exception of rheumatoid arthritis, pernicious anaemia and ulcerative colitis, reliable reporting figures of 70% or more were entered into a specifically created Microsoft® Access database, such that positive diagnoses were entered three were seen and rates were similar for case and control relatives. The confusion of rheumatoid arthritis with osteoarthritis was times: initial notification, relatives' verification and general practitioner confirmation. Thus, encoding errors were predictable and explains the positive predictive value of less than 50% in both cases and controls. minimized.
To explore under-reporting of autoimmune diseases within the control families, a randomly chosen, apparently unaffected, member of every third responding family was
Demographics of families
Of the 571 index cases, criteria for Poser category A were contacted. This individual was asked to confirm their date of birth, number of relatives in the family and whether they had met in 513 (89.8%), category B in 32 (5.6%) and category C in 26 (4.6%). There were 140 males and 431 females (ratio ever been diagnosed with any of the specified conditions. Statistical analysis was carried out using the proportion of 1 : 3). Disability scores (from the expanded disability status scale) ranged from 0 to 9.5, with 217 having scores less than families in whom one or more relatives had the specified condition. A χ 2 test for trend (χ 2 trend ) was used to test for 4, 274 from 4 to 7, and 80 greater than 7. A relapsingremitting course was reported in 339 (59.4%), with 180 dose effect of genetic loading between control, simplex and multiplex families with unitary weighting (Fleiss, 1981) . The (31.5%) having secondary progressive disease and 52 (9.1%) primary progressive disease. These figures accord well with χ 2 test was used for comparisons between two groups and the odds ratio, which very closely approximates to the relative previously reported cross-sectional surveys of patients with multiple sclerosis (Miller et al., 1992) . risk in large samples, used to calculate the sibling risk. The age-and sex-adjusted prevalence figure for autoimmune
The index controls were spouses or partners in 73%. Of the control relatives, 22% were no longer living as opposed disease in control relatives was calculated using the UK midcensus estimates for 1997 (Matheson and Pullinger, 1999) .
to only 2% of case relatives. Deceased relatives were included in the analysis, except where otherwise stated. There were 375 control, 508 simplex and 63 multiplex families. The 11% frequency of multiple sclerosis cases with a co-affected
Results
first-degree relative is consistent with UK population figures (Robertson et al., 1996) .
Response rates
The overall response rates for usable questionnaires were There was a co-affected sibling in 49 of the multiplex families. Because of the way in which these families were 375 of 647 (58%) for controls and 571 of 753 (76%) for cases. A breakdown of recruitment and reasons for exclusion identified (i.e. affected sibling pair), they were predictably larger. The 49 co-affected siblings have therefore been are given in Fig. 1 . Analysis of the non-responding cases revealed that they were twice as likely to have an incomplete excluded so as to avoid any potential bias from including siblings with multiple sclerosis and concurrent autoimmune address (e.g. missing postcode) and were more likely to have disease (in fact only one of the 49 had an autoimmune of control relatives. Seven control relatives also had a diagnosis of multiple sclerosis, which was confirmed in all disease) and to equilibrate the sibship sizes. The mean ages of relatives, the sibship sizes and sex distribution for siblings six of the living cases. These families remained in the analysis as controls. were comparable between the three groups ( Table 3 ). The figure of 2.5 for the mean number of offspring per family is slightly higher than the population figure for mothers 40 years ago of just over 2 (Harris, 1997) . This difference may
Autoimmune disease in control relatives
The prevalence data for autoimmune disease in all control merely reflect the fact that, by the very nature of this study, no families without children were included. When sibling relatives are summarized by age in Fig. 2 . These give an age-and sex-adjusted prevalence of 2.3% for the selected numbers for one-third of the control families were checked with a second family member, five additional siblings were autoimmune diseases in the control relatives, which compares well with the predicted population figure of 2.5%. Ninetyidentified. When extrapolated to the entire set of control families, this only constitutes an error of 1% in the number one of 117 unaffected control relatives who were contacted autoimmune disease in living mothers and living fathers were calculated separately (Fig. 4) . These data combined also responded. None reported suffering from any of the listed show a statistically significant relationship (χ 2 trend ϭ 4.06, autoimmune diseases, confirming that under-reporting was P ϭ 0.04). not a significant problem.
The association with all autoimmune disease was seen for each individual condition (Fig. 5) . The relationships for Hashimoto's disease/autoimmune hypothyroidism and
Autoimmune disease in case and control
Graves' disease/autoimmune hyperthyroidism reach statistical significance in their own right, with Graves' disease/
families
The number of families where one or more relatives had one primary hyperthyroidism appearing to contribute the largest effect. The result for systemic lupus erythematosus just of the selected autoimmune diseases was 44 of 375 (11.7%) in control families, 80 of 508 (15.7%) in simplex families fails to reach significance at the 5% level (P ϭ 0.051).
In the case of rheumatoid arthritis, deceased relatives and 16 of 63 (27%) in multiplex families (χ 2 trend ϭ 8.95, P ϭ 0.003). Figure 3 shows this result graphically and also account for half of the unconfirmed control families and diagnostic confirmation rates are generally low for all family demonstrates the proportion of families in which at least one relative with a diagnosis of autoimmune disease was types (Fig. 5C ). In view of the low positive predictive value of around 40% for rheumatoid arthritis seen in living relatives, confirmed by the general practitioner. The result for the control families is slightly higher than that predicted by the it is reasonable to presume that a fair proportion of these unconfirmed rheumatoid arthritis diagnoses are incorrect and population data (3.5 ϫ 2.5% ϭ 8.8%) and reflects the mean age of 56 years seen for all relatives. To remove any potential mistaken for osteoarthritis. If rheumatoid arthritis is excluded from the analysis, the result becomes more significant (P ϭ bias due to disparity in the sibship size, sibling sex distribution or proportion of deceased parents, the prevalences of 0.000035) indicating that our quoted P-value is likely to be a conservative estimate. This result remains significant even carefully matched for age and sex. However, calculated sexadjusted prevalence rates for autoimmune disease were 2% when the non-responding case families are included on the basis that they had no autoimmune disease (χ 2 trend ϭ 8.49, in the index cases and 2.73% in the index controls (Z ϭ 0.74, P ϭ 0.46). These figures are comparable with a P ϭ 0.0036).
There were no type 1 diabetic relatives in the multiplex population prevalence of 2.5% for these autoimmune diseases in the UK. The figures for individual conditions are listed in families where one or two might have been expected. Only two cases of myasthenia gravis were reported, one in a Table 4 and most agree with population data. The numbers of cases and controls make interpretation of the apparently deceased control relative and the second in a living case relative in whom the general practitioner was 'uncertain' lower rate of autoimmune disease in cases impossible, but do at least indicate that there has been no bias towards about the diagnosis; this individual was excluded. No cases of Addison's disease were reported. autoimmune disease in the cases who responded. There were no cases of pernicious anaemia, systemic lupus erythematosus, myasthenia gravis or Addison's disease among the index cases and controls.
Sibling risk for autoimmune disease
The number of siblings with one or more autoimmune diseases was 10 of 565 (1.8%) for controls and 30 of 982 (3.1%) for cases. The sex-adjusted sibling (λ s ) risk is 1.65
Discussion
(95% confidence interval, 1.0-3.4).
Here we show an increased risk of other autoimmune diseases in the relatives of patients with multiple sclerosis. This study was large with high response rates and diagnostic
Other conditions in families
confirmation, and used a conservative family based method Psoriasis showed a similar trend to the selected antibody of statistical analysis. The sex distributions of the index cases associated autoimmune diseases (Fig. 6A ). Inflammatory and controls are clearly influenced by the use of spouses/ bowel disease showed no association with multiple sclerosis partners as controls. However, these individuals were not (Fig. 6B) . The non-autoimmune control diseases, myocardial used for the primary analysis and only their relatives were infarction and type 2 diabetes mellitus, and asthma showed included. Fears that men may be less diligent in reporting no familial relationship with multiple sclerosis (Fig. 6C-E) .
family history data were not born out, as the frequencies of all conditions studied in the control families match published figures for the UK population, and random sampling for
Autoimmune disease in index cases and
under-reporting of autoimmune disease failed to identify missed cases in the control families. In a condition which controls An estimate of prevalence for autoimmune disease in index predominantly affects women, such as multiple sclerosis, cases will tend to come from families with a higher proportion cases and controls would require several thousand participants The proportion of unconfirmed (striped) and confirmed (white) cases for inflammatory bowel disease. Error bars and hypothesis test statistic are based on combined data for present data only. Because heart disease was frequently reported as a cause of death in deceased relatives, and could not always be validated only living relatives have been analysed for myocardial infarction, and families normalized to a structure of two parents, one brother and one sister. of daughters, and this effect is further increased in affected with multiple sclerosis is small, suggesting that genetic factors responsible for this apparent autoimmune diathesis sibling pair families. In addition, the sex distribution of the index cases does have a subtle effect on the sibship sex contribute only a small part to genetic susceptibility in multiple sclerosis. Since λ s for multiple sclerosis is distribution, with women tending to have a slightly higher proportion of sisters and vice versa for men. However, approximately 20, the figure of 1.65 attributable to the risk of non-specific autoimmunity indicates that disease specific variations in the sibship sex distribution observed in the present study would not account for differences in the rates genetic factors are more significant. Autoimmune thyroid disease shows the strongest effect, of autoimmune disease seen in the three sets of relatives, particularly as it is the parents who contribute the largest but this may reflect the high prevalence compared with other autoimmune conditions. Using different methodology, effect. We therefore conclude that the antibody associated autoimmune diseases studied are more frequent among firstwithout control data, a recent French study found a lower overall rate of autoimmune disease in first-degree relatives degree relatives of patients with multiple sclerosis than wellmatched controls, whereas non-autoimmune diseases show of patients with multiple sclerosis than in our study, but also reported a high prevalence of Graves' disease (Heinzlef et al., no such relationship. In addition, the data indicate increasing genetic load for autoimmune disease among members of 1999). This finding is of particular interest since a proportion of patients with multiple sclerosis treated with interferon-β multiplex families. However, the overall risk of other autoimmune diseases observed in relatives of our patients (Rotondi et al., 1998 ) and one-third of patients receiving Campath-1H (Coles et al., 1999) develop Graves' disease. 1997). Genome screens for type 1 diabetes mellitus (Todd and Farrall, 1996) , systemic lupus erythematosus (Gaffney This suggests a specific relationship between Graves' disease and multiple sclerosis, although the mechanism is not yet et al., 1998), rheumatoid arthritis (Cornelis et al., 1998) and multiple sclerosis (Ebers et al., 1996; Haines et al., 1996 ; understood. The finding of no relatives with type 1 diabetes in the multiplex families may have arisen purely by chance, Sawcer et al., 1996; Kuokkanen et al., 1997) have failed to identify any common loci. However, clustering of non-major but could indicate a specific relationship between type 1 diabetes and multiple sclerosis: a higher genetic load histocompatibility complex candidate susceptibility loci for these conditions has already been noted (Becker et al., 1998) . predisposing towards multiple sclerosis may be relatively protective against autoimmune diabetes. For example, the Since there is a definite familial recurrence risk for multiple sclerosis and other autoimmune diseases, it is logical to class 2 major histocompatibility complex allele HLA-DR2, which is clearly associated with multiple sclerosis (Coraddu consider combined linkage studies or to perform a metaanalysis of the available independent genome screens to et al., 1998), is protective in type 1 diabetes mellitus (Noble et al., 1996) in northern Europeans.
identify loci which confer susceptibility to autoimmunity independent of the disease phenotype. Psoriasis shows a similar trend of genetic loading in simplex and multiplex families and this confirms the previously reported increased risk of psoriasis within multiple in both case and control families. Taken together, these results provide no evidence supporting an increased prevalence of Barker JN. Psoriasis as a T cell-mediated autoimmune disease.
inflammatory bowel disease within first-degree relatives of [Review] . Hosp Med 1998; 59: 530-3. patients with multiple sclerosis. ( De Keyser, 1988; Wynn et al., 1990) . The finding of an Am J Med 1994; 96: 457-62. increased familial rate of autoimmune disease without a corresponding increase in patients with multiple sclerosis Bernstein CN, Blanchard JF, Rawsthorne P, Wajda A. Epidemiology seems counterintuitive. However, this finding is compatible of Crohn's disease and ulcerative colitis in a central Canadian with the hypothesis that while a number of shared genotypes province: a population-based study. Am J Epidemiol 1999; 149: 916-24. may underlie genetic predisposition to autoimmunity, the specific phenotype in individual family members is Bias WB, Reveille JD, Beaty TH, Meyers DA, Arnett FC. Evidence determined by disease specific genes or external factors, and that autoimmunity in man is a Mendelian dominant trait. Am J that to some extent these phenotypic determinants may be Hum Genet 1986; 39: 584-602. mutually exclusive. This interpretation was the conclusion of Brandrup F, Green A. The prevalence of psoriasis in Denmark. a previous study of familial autoimmunity (Bias et al., 1986) . Acta Derm Venereol 1981; 61: 344-6. Most autoimmune diseases are thought to arise from this model is supported by the results of twin studies (Leslie Lancet 1999; 354: 1691-5. and Hawa, 1994) . The majority of autoimmune diseases also have a recognized HLA association. However, these disease Confavreux C, Hutchinson M, Hours MM, Cortinovis-Tourniaire P, Moreau T. Rate of pregnancy-related relapse in multiple sclerosis.
associations are specifically different (Heward and Gough, 
